| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Marshall H. Woodworth | Chief Financial Officer | 2025-06-04 | 14,200 | $0.70 | $9.94kBuy |
| Donga St Co Ltd | 10% Owner | 2025-05-08 | 4,647,887 | $0.71 | $3.30MBuy |
| Hyung Heon Kim | CEO President | 2025-03-01 | 2,795 | $1.46 | $4.08kSell |
| Marshall H. Woodworth | Chief Financial Officer | 2025-03-01 | 3,417 | $1.46 | $4.99kSell |
| Hyung Heon Kim | CEO President | 2024-11-30 | 2,867 | $2.55 | $7.31kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Donga St Co Ltd | 41.31% | 9,995,679 | $9.75M | Insider |
| Na Yeon Kim | 25.53% | 6,178,535 | $6.02M | Insider |
| Einvestment Inc | 24.86% | 6,016,669 | $5.87M | Insider |
| Jeong Gyun Oh | 8.50% | 2,057,893 | $2.01M | Insider |
| Charles Phd Bisgaier | 5.99% | 1,450,362 | $1.41M | Insider |
| Steven R. Phd Gullans | 5.08% | 1,230,252 | $1.20M | Insider |
| Goldman Sachs Group Inc | 5.04% | 1,220,502 | $1.19M | Insider |
| Akash Bakshi | 3.77% | 913,085 | $890.26k | Insider |
| David Lowenschuss | 3.33% | 806,247 | $786.09k | Insider |
| Jk Biopharma Solutions Inc | 3.31% | 800,170 | $780.17k | Insider |